|Articles|March 10, 2022
Identification of Insulin Oligomeric States v2
Author(s)Wyatt Technology
SEC-MALS identifies monomers, dimers, hexamers and higher aggregates of insulin to determine optimal formulation, storage and administration conditions.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
4
Generative AI and Adaptive Trials Shape Future Biotech Development
5